VKH
CLVS

Virtu KCG Holdings’s Clovis Oncology, Inc. CLVS Stock Holding History

Virtu KCG Holdings’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$374K Buy
+3,993
New +$244K 0.01% 1423
2017
Q1 		– Sell
-7,890
Closed -$350K – 3923
2016
Q4 		$350K Buy
+7,890
New +$278K 0.01% 1916

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Virtu KCG Holdings's CLVS Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Clovis Oncology, Inc. (CLVS) in Q2 2017: 3,993 shares worth $374K. The stake represents 0.01% of the portfolio and ranks #1423 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in CLVS as recently as Q4 2016.

Virtu KCG Holdings first reported a position in CLVS in Q4 2016 and has held it in 2 quarters since. 271 funds tracked by Wall St. Rank hold CLVS as of Q2 2017.

  • Virtu KCG Holdings held 3,993 shares of Clovis Oncology, Inc. worth $374K as of Q2 2017.
  • Clovis Oncology, Inc. was a new Virtu KCG Holdings position in Q2 2017.
  • Clovis Oncology, Inc. made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1423 holding.
  • Virtu KCG Holdings first reported a position in Clovis Oncology, Inc. in Q4 2016 and has held it in 2 quarters since.
  • 271 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.